Arthur Hayes, co-founder of the cryptocurrency exchange BitMEX, is making strides toward a new career in biotechnology by taking on a leadership role in a stem cell company.
Arthur Hayes and His New Direction
Arthur Hayes, recently pardoned by U.S. President Donald Trump, has taken a board seat at a stem cell company. Hayes himself has been a patient at this firm for over a year. In an interview, he stated: *“I want to live as long as possible, as healthy as possible.”*
Crypto Leaders in Longevity
Hayes is not alone in his interest in biotechnology. Many well-known figures from the crypto industry are investing in longevity projects. For instance, Vitalik Buterin, co-founder of Ethereum, donated millions to aging research, while Brian Armstrong, CEO of Coinbase, co-founded NewLimit, a startup that raised $130 million.
Connection to the Crypto Industry and the Future
Despite his new focus on biotechnology, Hayes remains actively involved in the cryptocurrency sector, making investments and sharing his market views. His family office, Maelstrom, funds Bitcoin developers and continues to invest in digital asset companies. In light of Trump's pardon, Hayes sees this as a validation, stating: *“If the president of the empire creates his own memecoin, it gives license to other politicians to use memecoins for campaign financing.”*
Arthur Hayes is actively expanding his horizons beyond cryptocurrency, linking new technological investments with health and longevity improvements. His shift towards biotechnology illustrates the changing interests of many crypto investors.
